AU2251288A – Sequential improved method for treatment of human blood- clotting factor products
– Google Patents
AU2251288A – Sequential improved method for treatment of human blood- clotting factor products
– Google Patents
Sequential improved method for treatment of human blood- clotting factor products
Info
Publication number
AU2251288A
AU2251288A
AU22512/88A
AU2251288A
AU2251288A
AU 2251288 A
AU2251288 A
AU 2251288A
AU 22512/88 A
AU22512/88 A
AU 22512/88A
AU 2251288 A
AU2251288 A
AU 2251288A
AU 2251288 A
AU2251288 A
AU 2251288A
Authority
AU
Australia
Prior art keywords
treatment
improved method
human blood
clotting factor
factor products
Prior art date
1987-05-15
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU22512/88A
Inventor
Alan I. Rubinstein
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
1987-05-15
Filing date
1988-05-13
Publication date
1988-12-06
1988-05-13
Application filed by Individual
filed
Critical
Individual
1988-12-06
Publication of AU2251288A
publication
Critical
patent/AU2251288A/en
Status
Abandoned
legal-status
Critical
Current
Links
Espacenet
Global Dossier
Discuss
Classifications
C—CHEMISTRY; METALLURGY
C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
C12N9/14—Hydrolases (3)
C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
C12N9/6424—Serine endopeptidases (3.4.21)
C12N9/647—Blood coagulation factors not provided for in a preceding group or according to more than one of the proceeding groups
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
A61K39/00—Medicinal preparations containing antigens or antibodies
A61K39/12—Viral antigens
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
A61K39/00—Medicinal preparations containing antigens or antibodies
A61K39/12—Viral antigens
A61K39/29—Hepatitis virus
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
A61L2/0011—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using physical methods
A61L2/0023—Heat
C—CHEMISTRY; METALLURGY
C07—ORGANIC CHEMISTRY
C07K—PEPTIDES
C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
C07K14/745—Blood coagulation or fibrinolysis factors
C07K14/75—Fibrinogen
C—CHEMISTRY; METALLURGY
C07—ORGANIC CHEMISTRY
C07K—PEPTIDES
C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
C07K14/745—Blood coagulation or fibrinolysis factors
C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
A61K38/00—Medicinal preparations containing peptides
C—CHEMISTRY; METALLURGY
C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
C12N2770/00011—Details
C12N2770/24011—Flaviviridae
C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
C12N2770/24234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
AU22512/88A
1987-05-15
1988-05-13
Sequential improved method for treatment of human blood- clotting factor products
Abandoned
AU2251288A
(en)
Applications Claiming Priority (3)
Application Number
Priority Date
Filing Date
Title
US5015387A
1987-05-15
1987-05-15
US050153
1987-05-15
US193449
1988-05-12
Publications (1)
Publication Number
Publication Date
AU2251288A
true
AU2251288A
(en)
1988-12-06
Family
ID=21963642
Family Applications (1)
Application Number
Title
Priority Date
Filing Date
AU22512/88A
Abandoned
AU2251288A
(en)
1987-05-15
1988-05-13
Sequential improved method for treatment of human blood- clotting factor products
Country Status (3)
Country
Link
EP
(1)
EP0413687A1
(en)
AU
(1)
AU2251288A
(en)
WO
(1)
WO1988008710A1
(en)
Families Citing this family (5)
* Cited by examiner, † Cited by third party
Publication number
Priority date
Publication date
Assignee
Title
AT402891B
(en)
*
1991-06-20
1997-09-25
Immuno Ag
METHOD FOR PRODUCING AN INACTIVATED BLOOD PRODUCT
AT399818B
(en)
*
1992-04-24
1995-07-25
Immuno Ag
METHOD FOR PRODUCING A HIGH PURIFIED VIRUS-SAFE FACTOR VIII PREPARATION
JP3133338B2
(en)
*
1992-12-16
2001-02-05
イムノ・アクチエンゲゼルシャフト
Methods for preparing virally safe biological compositions
DE4320294A1
(en)
*
1993-06-18
1994-12-22
Immuno Ag
Use of human protein C to prevent and treat platelet deposits
GB9424732D0
(en)
*
1994-12-08
1995-02-08
Common Services Agency
Heat treated blood plasma proteins
Family Cites Families (6)
* Cited by examiner, † Cited by third party
Publication number
Priority date
Publication date
Assignee
Title
JPS5874617A
(en)
*
1981-10-28
1983-05-06
Green Cross Corp:The
Heat-treating method of aqueous solution containing blood coagulation factor 8 derived from human
US4456590B2
(en)
*
1981-11-02
1989-05-30
Heat treatment of lyphilized blood clotting factor viii concentrate
US4486410A
(en)
*
1984-02-09
1984-12-04
Armour Pharmaceutical Company
Heat defibrinogenation of AHF preparation
AT389815B
(en)
*
1984-03-09
1990-02-12
Immuno Ag
METHOD FOR INACTIVATING VARIABLE FILTERABLE DISEASERS IN BLOOD PRODUCTS
JPH0669961B2
(en)
*
1984-09-25
1994-09-07
株式会社ミドリ十字
Immunoglobulin heat treatment method
JPH0769585B2
(en)
*
1987-12-14
1995-07-31
富士写真フイルム株式会社
Method for producing photographic silver halide emulsion
1988
1988-05-13
EP
EP88906718A
patent/EP0413687A1/en
not_active
Ceased
1988-05-13
AU
AU22512/88A
patent/AU2251288A/en
not_active
Abandoned
1988-05-13
WO
PCT/US1988/001587
patent/WO1988008710A1/en
not_active
Application Discontinuation
Also Published As
Publication number
Publication date
EP0413687A4
(en)
1990-05-14
EP0413687A1
(en)
1991-02-27
WO1988008710A1
(en)
1988-11-17
Similar Documents
Publication
Publication Date
Title
AU1676588A
(en)
1989-01-12
Treatment of materials
AU2169488A
(en)
1990-03-08
Scalp treatment method
GB8704089D0
(en)
1987-03-25
Method of treatment
AU2644888A
(en)
1989-06-08
Method of healing wounds in horses
AU1002488A
(en)
1988-07-14
Method for the treatment of fish and meat
GB8428747D0
(en)
1984-12-27
Products for treatment of human body
AU613355B2
(en)
1991-08-01
Method for treating skin diseases
AU2251288A
(en)
1988-12-06
Sequential improved method for treatment of human blood- clotting factor products
AU5183590A
(en)
1991-02-22
Sequential heat treatment of blood-clotting factor products
AU2564688A
(en)
1989-05-25
Treatment of fibromyalgia
GB8718025D0
(en)
1987-09-03
Method of treatment
GB8704090D0
(en)
1987-03-25
Method of treatment
GB8704088D0
(en)
1987-03-25
Method of treatment
GB8820939D0
(en)
1988-10-05
Novel method of treatment
BG47873A1
(en)
1990-10-15
Method for expression of gene of human alpha- 1- interferon
PL271057A1
(en)
1989-09-18
Method of making therapeutic cream for treatment of dermatopathies, in particular burns
PL295938A1
(en)
1993-04-05
Method of obtaining collagen medical products
GB8822016D0
(en)
1988-10-19
Method of treatment
GB8808914D0
(en)
1988-05-18
Method of treatment
GB8804204D0
(en)
1988-03-23
Method of treatment
GB8804206D0
(en)
1988-03-23
Method of treatment
GB8822019D0
(en)
1988-10-19
Method of treatment
GB8801688D0
(en)
1988-02-24
Method of treatment
GB8822015D0
(en)
1988-10-19
Method of treatment
GB8822014D0
(en)
1988-10-19
Method of treatment
None